Have anyone tried the Ovation RNA-seq system from NuGen? I have small amounts of input RNA and consider to use this system to have enough starting material for RNA-seq. Any experience?
Unconfigured Ad
Collapse
X
-
Users of the Ovation RNA-Seq System
We have several conference posters and webinars posted on our web site to illustrate studies with low inputs of total RNA using the Ovation RNA-Seq System: http://www.nugeninc.com/nugen/index....na-seq-system/
Best,
SteveLast edited by kainsteven; 06-11-2010, 11:57 AM.
-
I love the NuGen kits. We routinely use them to generate random cDNA from viral RNA samples. If you follow with the Exon Module the products can be used for beautiful Illumina libraries./\/\/\/\/\/\/\/\/\/\/\/\/\/\/\/\/
Shannon L Johnson PhD
Los Alamos National Laboratory
Joint Genome Insitute
[email protected]
Comment
-
Ovation RNA-Seq, 3'-DGE and Encore NGS Library Systems
It is no longer necessary to use the exon module to produce the double-stranded cDNA. We have packaged the complete solution for producing a dscDNA starting with total RNA in either an RNA-Seq or 3'-DGE experiment. Each of these workflows integrate directly with our Encore NGS Library Systems for the Illumina platform. Workflow time from total RNA to cBot is about 9 hours.
Steve
Comment
-
I'm having a difficult time understanding how, in the absence of a polyA selection or a ribosomal reduction method, and through the use of a mix of oligo dT and random primers, NuGEN is able to achieve such purportedly low % mapping to rRNA (~ 3-3.5%) -- are the random primers not_so_random, i.e., do they select against rRNA sequences?
Anyone try NuGEN in house and obtain similar metrics as reported in NuGEN's product literature? (http://www.nugeninc.com/tasks/sites/...ov_rna_seq.pdf)
Curious,
-Paul
Comment
-
We've used them to sequence viruses along with host "background" sequence. With one channel of SE 76bp Illumina we get about 90% coverage of the viral genome, and little host rRNA./\/\/\/\/\/\/\/\/\/\/\/\/\/\/\/\/
Shannon L Johnson PhD
Los Alamos National Laboratory
Joint Genome Insitute
[email protected]
Comment
Latest Articles
Collapse
-
by SEQadmin2
Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?
Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating...-
Channel: Articles
10-14-2026, 09:55 AM -
-
by SEQadmin2
Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.
We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing...-
Channel: Articles
-
ad_right_rmr
Collapse
News
Collapse
| Topics | Statistics | Last Post | ||
|---|---|---|---|---|
|
Started by SEQadmin2, 10-22-2026, 11:13 AM
|
0 responses
45 views
0 reactions
|
Last Post
by SEQadmin2
10-22-2026, 11:13 AM
|
||
|
Started by SEQadmin2, 10-22-2026, 10:48 AM
|
0 responses
34 views
0 reactions
|
Last Post
by SEQadmin2
10-22-2026, 10:48 AM
|
||
|
Started by SEQadmin2, 10-15-2026, 10:52 AM
|
0 responses
44 views
0 reactions
|
Last Post
by SEQadmin2
10-15-2026, 10:52 AM
|
||
|
Started by SEQadmin2, 10-14-2026, 05:39 AM
|
0 responses
45 views
0 reactions
|
Last Post
by SEQadmin2
10-14-2026, 05:39 AM
|
Comment